June Sherie Almenoff, Director at Ohr Pharmaceutical Inc (OHRP), bought 6,000 shares at $6.75 ($41K) on 2015-02-06, disclosed to the SEC on 2015-02-10.
Open-market purchase of $40k OHRP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| BCLI | BUY | 2019-01-08 | $5K | — | Filing → |
| INNT | BUY | 2018-08-28 | $7K | — | Filing → |
| OHRP | BUY | 2014-06-30 | $27K | — | Filing → |